Gloria Y. Kwei, Ph.D.
Gloria Kwei draws on extensive experience from her tenure at Merck and Novartis, and her background in nutritional science, to identify and characterize key attributes to enable project progression. She and her teams had responsibility to integrate biology, pharmacology and phys/chemical sciences into a PKPD, and dose/regimen/formulation strategy, starting from research, and translation into preclinical development and human trials.
Gloria built the DMPK function and was a member of the site research management team when Merck opened a new site in Boston. Gloria later joined Novartis as global head for the early DMPK discipline, with strategic and operational responsibilities covering the research to clinical Proof of Concept space. Responsibilities grew from a small molecule focus to include therapeutic proteins and cell/gene therapy. Over the years these efforts contributed to a number of new entities that progressed into late phase development and became successful commercial products.
During her time at Merck, Gloria was the functional representative on an external research initiative, tapping innovation and capabilities at CROs and biotech companies to build a pipeline with external partners. This experienced helped her to develop external DMPK capability strategies, including executing partnered programs, at Novartis (NIBR).
Gloria received her PhD in Nutrition from the University of California, Berkeley.
Gloria built the DMPK function and was a member of the site research management team when Merck opened a new site in Boston. Gloria later joined Novartis as global head for the early DMPK discipline, with strategic and operational responsibilities covering the research to clinical Proof of Concept space. Responsibilities grew from a small molecule focus to include therapeutic proteins and cell/gene therapy. Over the years these efforts contributed to a number of new entities that progressed into late phase development and became successful commercial products.
During her time at Merck, Gloria was the functional representative on an external research initiative, tapping innovation and capabilities at CROs and biotech companies to build a pipeline with external partners. This experienced helped her to develop external DMPK capability strategies, including executing partnered programs, at Novartis (NIBR).
Gloria received her PhD in Nutrition from the University of California, Berkeley.